Theranostic Agents in Musculoskeletal Disorders

Area of Science:

• Nanomedicine and Theranostics
• Biomedical Engineering
• Molecular Imaging

Background:

• Theranostic strategies integrate therapeutic and diagnostic capabilities into a single agent.
• Multifunctional theranostic modalities are increasingly utilized for disease detection, quantification, and therapy response monitoring.
• Musculoskeletal disorders represent a significant area for theranostic application.

Purpose of the Study:

• To review emerging theranostic nanomedicine approaches for musculoskeletal disorders.
• To provide insights for developing efficient theranostic agents for clinical use.
• To explore preclinical applications of radionuclide nanotheranostic agents.

Main Methods:

• Literature review of recent advancements in theranostic nanomedicine.
• Focus on agents targeting musculoskeletal pathologies.
• Examination of preclinical data for specific diseases.

Main Results:

• Emerging theranostic nanomedicine shows promise for musculoskeletal disorder detection and therapy.
• Various bioactive targeting strategies are being explored.
• Radionuclide nanotheranostic agents demonstrate potential in preclinical models.

Conclusions:

• Theranostic nanomedicine offers a promising avenue for managing musculoskeletal disorders.
• Further development is needed to translate preclinical findings into clinical applications.
• Targeted nanotheranostic agents can enhance diagnostic accuracy and therapeutic efficacy.